One Health research and innovation across borders to reduce the societal burden of antimicrobial resistance
The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) brings together 53 organisations from 30 countries in EU and beyond to address the challenges of antimicrobial resistance (AMR) across sectors and perspectives. The partnership deploys an integrated One Health approach, recognising that human, animal and plant health are interdependent and interlinked with the environment.
The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) brings together 53 organisations from 30 countries in EU and beyond, providing joint support to research and innovation and mobilising to address the challenges of antimicrobial resistance (AMR) with a One Health approach.
Antimicrobial resistance (AMR) is a global health challenge that affects human and animal health, food security and the environment. Immediate action is needed to boost AMR research and innovation (R&I) to better understand the biological mechanisms of resistance and evolution in microorganisms, as well as how AMR spreads, including social and human factors. There is a need for R&I to develop new treatments for infections and rapid and affordable diagnostics, and to improve current treatment solutions. New knowledge is also needed to improve surveillance methods and design innovative interventions to prevent and mitigate AMR.
Delivering R&I on this scale, and for impact, requires a collaborative and sustainable research community where capacities and assets are shared and used efficiently. Moreover, new knowledge must be implemented across many parts of the society to facilitate the translation and uptake of innovative solutions in real-word settings. Engagement from for example professional groups, civil society and regulators will be necessary to achieve sustainable change and impact.
Vision: To reduce the burden of antimicrobial resistance.
Mission: To boost One Health research and innovation leading to improved surveillance of resistant pathogens, better diagnostics and effective treatment of infections and to prevention measures reducing the use of antimicrobials and the spread of antimicrobial resistance.
The formation of the European Partnership One Health Antimicrobial Resistance (EUP OHAMR) was proposed by the European Commission within the framework of the Horizon Europe work programme 2023/2024, to align R&I funding and other activities among the EU countries and beyond. The partnership builds on the legacy of the Join Programming Initiative on Antimicrobial Resistance (JPIAMR), which has invested over 180 million Euro for research projects and networks between 2011 and 2024.
The EUP OHAMR brings together 53 organisations from 30 countries across EU and beyond, aiming to close knowledge gaps and break silos between sectors, disciplines and perspectives. As a global collaboration of organisations across society, the EUP OHAMR is expected to contribute towards the European One Health Action Plan against AMR and the Global Sustainable Development Goals (see links below).
The EUP OHAMR deploys an integrated One Health approach, recognising that human, animal and plant health are interdependent and interlinked with the environment.
Consortium of 53 organisations across 30 countries
10 year programme 2025-2035
Ambitious framework of programmes consisting of funding for R&I projects, capacity strengthening, knowledge translation, data exploitation and impact
Approx. €250 million pooled funding for R&I projects
Co-funded by the EU with up to €75 million towards the implementation of the programme and support for R&I projects
Coordinated by the Swedish Research Council, Sweden
The EUP OHAMR brings together 53 organisations across 30 countries from EU and beyond, providing joint support to research and innovation and mobilising to address the challenges of antimicrobial resistance.
Swedish Research Council (SRC), Sweden (Coordinator)
Austrian Agency for Health and Food Safety (AGES), Austria
Federal Ministry of Women, Science and Research (BMFWF), Austria
Austrian Science Fund (FWF), Austria
National Fund for Scientific Research (FNRS), Belgium
Research Foundation – Flanders (FWO), Belgium
Public Service of Wallonia (SPW), Belgium
European Public Health Alliance (EPHA), Belgium
European Patients Forum (EPF), Belgium
Health & Life Sciences Cluster Bulgaria (HLSC), Bulgaria
Canadian Institutes of Health Research (CIHR), Canada *
Czech Health Research Council (AZVCR), Czech Republic
Health Ministry of the Czech Republic (MZCR), Czech Republic
International Centre for Antimicrobial Resistance Solutions (ICARS), Denmark
Innovation Fund Denmark (IFD), Denmark
Estonian Research Council (ETAG), Estonia
Ministry of Regional Affairs and Agriculture (REM), Estonia
Research Council of Finland (AKA), Finland
French National Research Agency (ANR), France
Federal Ministry of Education and Research (BMBF), Germany
German Aerospace Center (DLR), Germany
National Research, Development and Innovation Office (NKFIH), Hungary
Department of Agriculture, Food and the Marine (DAFM), Ireland
Taighde Éireann – Research Ireland (TÉ-RI), Ireland
Health Research Board (HRB), Ireland
Ministry of Health – Chief Scientist Office (CSO-MOH), Israel
Agency for the Promotion of European Research (APRE), Italy
Regional Foundation for Biomedical Research (FRRB), Italy
Italian Ministry of Health (MOH-IT), Italy
Toscana Life Sciences Foundation (TLS), Italy
Latvian Council of Science (LZP), Latvia
Research Council of Lithuania (LMT), Lithuania
Science Malta (XM), Malta
National Agency for Research and Development (NARD), Moldova
KIT Royal Tropical Institute (KIT), Netherlands
Dutch Research Council (NWO), Netherlands
Netherlands Organisation for Health Research and Development (ZonMw), Netherlands
Research Council of Norway (RCN), Norway
National Science Centre (NCN), Poland
Agency for Clinical Research and Biomedical Innovation (AICIB), Portugal
Foundation for Science and Technology (FCT), Portugal
Slovak Centre of Scientific and Technical Information (CVTI SR), Slovakia
Department of Science and Innovation (DSI), South Africa
South African Medical Research Council (SAMRC), South Africa
State Research Agency of Spain (AEI), Spain
Aragon Institute of Health Sciences (IACS), Spain
Institute of Health Carlos III (ISCIII), Spain
Global Antibiotic Research and Development Partnership (GARDP), Switzerland *
Swiss National Science Foundation (SNSF), Switzerland *
Scientific and Technological Research Council of Türkiye (TÜBİTAK), Türkiye
Department of Health and Social Care (DHSC), United Kingdom
United Kingdom Research and Innovation (UKRI), United Kingdom
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), USA
*Associated partner